I want to have an honest conversation with you about something that has been transforming how we approach medicine here at AgeRejuvenation, and that is peptide therapy
Explore our full range of Critical Care Injectables
How quickly you see improvement depends on how consistently you have treatments, your general health, and your metabolism
decades of cosmetic and wound-healing literature No multi-center RCT BPC-157: Limited, Emerging Clinical Evidence 100+ preclinical repair studies Human evidence is thin but real PL-14736 (its clinical-development name) reached abstract-level Phase 1/2 in ulcerative colitis A modern hamstring tendon Phase 2 RCT is recruiting, and an intra-articular knee case series exists Clean early-phase safety
Carry higher interaction risk than structural peptides like BPC-157 or collagen fragments
The best you can do is have an open conversation with your provider, considering the minimal potential risks against your own comfort and needs when discussing your medication options
